Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/65645
Type
ArticleCopyright
Restricted access
Embargo date
2030-12-31
Collections
- IOC - Artigos de Periódicos [12979]
Metadata
Show full item record
SUSCEPTIBILITY TO LEPROSY IS ASSOCIATED WITH PARK2 AND PACRG
Author
Mira, Marcelo Távora
Alcaïs, Alexandre
Thuc, Nguyen Van
Moraes, Milton Ozório
Di Flumeri, Celestino
Thai, Vu Hong
Phuong, Mai Chi
Huong, Nguyen Thu
Ba, Nguyen Ngoc
Khoa, Pham Xuan
Sarno, Euzenir Nunes
Alter, Andrea
Montpetit, Alexandre
Moraes, Maria Elisa
Moraes, José Roberto Feresin
Doré, Carole
Gallant, Caroline J.
Lepage, Pierre
Verner, Andrei
Vosse, Esther van de
Hudson, Thomas J.
Abel, Laurent
Schurr, Erwin
Alcaïs, Alexandre
Thuc, Nguyen Van
Moraes, Milton Ozório
Di Flumeri, Celestino
Thai, Vu Hong
Phuong, Mai Chi
Huong, Nguyen Thu
Ba, Nguyen Ngoc
Khoa, Pham Xuan
Sarno, Euzenir Nunes
Alter, Andrea
Montpetit, Alexandre
Moraes, Maria Elisa
Moraes, José Roberto Feresin
Doré, Carole
Gallant, Caroline J.
Lepage, Pierre
Verner, Andrei
Vosse, Esther van de
Hudson, Thomas J.
Abel, Laurent
Schurr, Erwin
Affilliation
McGill University. Departments of Human Genetics, Medicine and Biochemistry. McGill Centre for the Study of Host Resistance. Montreal, QC, Canada / Pontifícia Universidade Católica do Paraná. Centro de Ciências Biológicas e da Saúde. Curitiba, PR, Brasil.
Université de Paris René Descartes. Faculté de Médecine Necker. Institut National de la Santé et de la Recherche Médicale. Laboratoire de Génétique Humaine des Maladies Infectieuses. Paris, France.
Hospital for Dermato-Venereology. Ho Chi Minh City, Vietnam.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
McGill University. Departments of Human Genetics, Medicine and Biochemistry. McGill Centre for the Study of Host Resistance. Montreal, QC, Canada.
Hospital for Dermato-Venereology. Ho Chi Minh City, Vietnam.
Hospital for Dermato-Venereology. Ho Chi Minh City, Vietnam.
Hospital for Dermato-Venereology. Ho Chi Minh City, Vietnam.
Hospital for Dermato-Venereology. Ho Chi Minh City, Vietnam.
Hospital for Dermato-Venereology. Ho Chi Minh City, Vietnam.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
McGill University. Departments of Human Genetics, Medicine and Biochemistry. McGill Centre for the Study of Host Resistance. Montreal, QC, Canada.
McGill University. Genome Québec Innovation Centre. Montreal, QC, Canada.
Ministério da Saúde. Instituto Nacional de Câncer. Laboratório de Imunogenética. Rio de Janeiro, RJ, Brasil.
Ministério da Saúde. Instituto Nacional de Câncer. Laboratório de Imunogenética. Rio de Janeiro, RJ, Brasil.
McGill University. Genome Québec Innovation Centre. Montreal, QC, Canada.
McGill University. Departments of Human Genetics, Medicine and Biochemistry. McGill Centre for the Study of Host Resistance. Montreal, QC, Canada.
McGill University. Genome Québec Innovation Centre. Montreal, QC, Canada.
McGill University. Genome Québec Innovation Centre. Montreal, QC, Canada.
Leiden University Medical Center. Department of Infectious Diseases. Leiden, The Netherlands / Leiden University Medical Center. Department of Immunohematology and Blood Transfusion. Leiden, The Netherlands.
McGill University. Departments of Human Genetics, Medicine and Biochemistry. McGill Centre for the Study of Host Resistance. Montreal, QC, Canada / McGill University. Genome Québec Innovation Centre. Montreal, QC, Canada.
Université de Paris René Descartes. Faculté de Médecine Necker. Institut National de la Santé et de la Recherche Médicale. Laboratoire de Génétique Humaine des Maladies Infectieuses. Paris, France.
McGill University. Departments of Human Genetics, Medicine and Biochemistry. McGill Centre for the Study of Host Resistance. Montreal, QC, Canada.
Université de Paris René Descartes. Faculté de Médecine Necker. Institut National de la Santé et de la Recherche Médicale. Laboratoire de Génétique Humaine des Maladies Infectieuses. Paris, France.
Hospital for Dermato-Venereology. Ho Chi Minh City, Vietnam.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
McGill University. Departments of Human Genetics, Medicine and Biochemistry. McGill Centre for the Study of Host Resistance. Montreal, QC, Canada.
Hospital for Dermato-Venereology. Ho Chi Minh City, Vietnam.
Hospital for Dermato-Venereology. Ho Chi Minh City, Vietnam.
Hospital for Dermato-Venereology. Ho Chi Minh City, Vietnam.
Hospital for Dermato-Venereology. Ho Chi Minh City, Vietnam.
Hospital for Dermato-Venereology. Ho Chi Minh City, Vietnam.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.
McGill University. Departments of Human Genetics, Medicine and Biochemistry. McGill Centre for the Study of Host Resistance. Montreal, QC, Canada.
McGill University. Genome Québec Innovation Centre. Montreal, QC, Canada.
Ministério da Saúde. Instituto Nacional de Câncer. Laboratório de Imunogenética. Rio de Janeiro, RJ, Brasil.
Ministério da Saúde. Instituto Nacional de Câncer. Laboratório de Imunogenética. Rio de Janeiro, RJ, Brasil.
McGill University. Genome Québec Innovation Centre. Montreal, QC, Canada.
McGill University. Departments of Human Genetics, Medicine and Biochemistry. McGill Centre for the Study of Host Resistance. Montreal, QC, Canada.
McGill University. Genome Québec Innovation Centre. Montreal, QC, Canada.
McGill University. Genome Québec Innovation Centre. Montreal, QC, Canada.
Leiden University Medical Center. Department of Infectious Diseases. Leiden, The Netherlands / Leiden University Medical Center. Department of Immunohematology and Blood Transfusion. Leiden, The Netherlands.
McGill University. Departments of Human Genetics, Medicine and Biochemistry. McGill Centre for the Study of Host Resistance. Montreal, QC, Canada / McGill University. Genome Québec Innovation Centre. Montreal, QC, Canada.
Université de Paris René Descartes. Faculté de Médecine Necker. Institut National de la Santé et de la Recherche Médicale. Laboratoire de Génétique Humaine des Maladies Infectieuses. Paris, France.
McGill University. Departments of Human Genetics, Medicine and Biochemistry. McGill Centre for the Study of Host Resistance. Montreal, QC, Canada.
Abstract
Leprosy is caused by Mycobacterium leprae and affects about 700,000 individuals each year. It has long been thought that leprosy has a strong genetic component, and recently we mapped a leprosy susceptibility locus to chromosome 6 region q25–q26 (ref. 3). Here we investigate this region further by using a systematic association scan of the chromosomal interval most likely to harbour this leprosy susceptibility locus. In 197 Vietnamese families we found a significant association between leprosy and 17 markers located in a block of approx. 80 kilobases overlapping the 5' regulatory region shared by the Parkinson's disease gene PARK2 and the co-regulated gene PACRG. Possession of as few as two of the 17 risk alleles was highly predictive of leprosy. This was confirmed in a sample of 975 unrelated leprosy cases and controls from Brazil in whom the same alleles were strongly associated with leprosy. Variants in the regulatory region shared by PARK2 and PACRG therefore act as common risk factors for leprosy.
Share